Biocept, Inc. - stock earnings
Stock symbol BIOC is outdated, potentially delisted? Maybe it is available on other exchange?
BIOC Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q4 | -9.7 million USD | -913000 USD |
| 2022Q3 | -5.5 million USD | 5.6 million USD |
| 2022Q2 | -5.3 million USD | 10.6 million USD |
| 2022Q1 | -2.8 million USD | 19.9 million USD |
| 2021Q4 | -3.0 million USD | 14.0 million USD |
| 2021Q3 | -624703 USD | 17.5 million USD |
| 2021Q2 | -1.8 million USD | 12.0 million USD |
| 2021Q1 | 2.6 million USD | 17.8 million USD |
| 2020Q4 | 1.9 million USD | 18.5 million USD |
| 2020Q3 | -4.9 million USD | 6.6 million USD |
BIOC Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -32.1 million USD | 25.9 million USD |
| 2021 | -2.8 million USD | 61.2 million USD |
| 2020 | -17.8 million USD | 27.5 million USD |
| 2019 | -25.1 million USD | 5.5 million USD |
| 2018 | -24.6 million USD | 3.3 million USD |
| 2017 | -21.6 million USD | 5.1 million USD |
BIOC
Price: $0.43
52 week price:
Earnings Per Share: -1.38 USD
P/E Ratio: 4.52
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 77200
Ebitda: -5.6 millionMarket Capitalization: 4.5 million